Asset Details
MbrlCatalogueTitleDetail
Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis
Anti-Bacterial Agents - therapeutic use
/ Burkholderia Infections - drug therapy
/ Burkholderia Infections - epidemiology
/ Burkholderia Infections - microbiology
/ Carrier State - epidemiology
/ Carrier State - microbiology
/ Corynebacterium Infections - drug therapy
/ Corynebacterium Infections - epidemiology
/ Corynebacterium Infections - microbiology
/ Cystic Fibrosis - epidemiology
/ Cystic Fibrosis - microbiology
/ Enterobacteriaceae - genetics
/ Enterobacteriaceae Infections - drug therapy
/ Enterobacteriaceae Infections - epidemiology
/ Enterobacteriaceae Infections - microbiology
/ Female
/ Haemophilus Infections - drug therapy
/ Haemophilus Infections - epidemiology
/ Haemophilus Infections - microbiology
/ Haemophilus influenzae - genetics
/ Humans
/ Infant
/ Male
/ Moraxellaceae Infections - drug therapy
/ Moraxellaceae Infections - epidemiology
/ Moraxellaceae Infections - microbiology
/ Real-Time Polymerase Chain Reaction
/ RNA, Ribosomal, 16S - genetics
/ Staphylococcal Infections - drug therapy
/ Staphylococcal Infections - epidemiology
/ Staphylococcal Infections - microbiology
/ Staphylococcus aureus - genetics
/ Streptococcal Infections - drug therapy
/ Streptococcal Infections - epidemiology